Cargando…

HIV‐1 proviral landscape characterization varies by pipeline analysis

INTRODUCTION: HIV rebounds after cessation of antiretroviral therapy, representing a barrier to cure. To better understand the virus reservoir, analysis pipelines have been developed that categorize proviral sequences as intact or defective, and further determine the precise nature of the sequence d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferreira, Fernanda A, He, Qianjing, Banning, Stephanie, Roberts‐Sano, Olivia, Wilkins, Olivia, Kuritzkes, Daniel R., Tsibris, Athe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264403/ https://www.ncbi.nlm.nih.gov/pubmed/34235860 http://dx.doi.org/10.1002/jia2.25725

Ejemplares similares

Leveraging Novel Integrated Single-Cell Analyses to Define HIV-1 Latency Reversal
por: Zhao, Suhui, et al.
Publicado: (2021)

Barriers to a cure for HIV in women
por: Gianella, Sara, et al.
Publicado: (2016)

DNA engineered micromotors powered by metal nanoparticles for motion based cellphone diagnostics
por: Draz, Mohamed Shehata, et al.
Publicado: (2018)

NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology
por: Wright, Imogen A., et al.
Publicado: (2021)

The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4(+) T cells
por: Duette, Gabriel, et al.
Publicado: (2022)

Damaging the Integrated HIV Proviral DNA with TALENs
por: Strong, Christy L., et al.
Publicado: (2015)

An Improved Sequencing-Based Bioinformatics Pipeline to Track the Distribution and Clonal Architecture of Proviral Integration Sites
por: Rosewick, Nicolas, et al.
Publicado: (2020)

Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections
por: Anderson, Elizabeth M., et al.
Publicado: (2020)

Determination of RNA structural diversity and its role in HIV-1 RNA splicing
por: Tomezsko, Phillip J., et al.
Publicado: (2020)

HIV Impairs Lung Epithelial Integrity and Enters the Epithelium to Promote Chronic Lung Inflammation
por: Brune, Kieran A., et al.
Publicado: (2016)

HIV-1 Proviral Transcription and Latency in the New Era
por: Shukla, Ashutosh, et al.
Publicado: (2020)

SHIV-162P3 Infection of Rhesus Macaques Given Maraviroc Gel Vaginally Does Not Involve Resistant Viruses
por: Tsibris, Athe M. N., et al.
Publicado: (2011)

A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects
por: Brown, Jennifer, et al.
Publicado: (2014)

Intragenic proviral elements support transcription of defective HIV-1 proviruses
por: Kuniholm, Jeffrey, et al.
Publicado: (2021)

Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo
por: Tsibris, Athe M. N., et al.
Publicado: (2009)

T cell-tropic HIV efficiently infects alveolar macrophages through contact with infected CD4+ T cells
por: Schiff, Abigail E., et al.
Publicado: (2021)

Epigenetic modifications of HIV proviral LTRs: potential targets for cure
por: Doerfler, W, et al.
Publicado: (2012)

Differential proviral latency of the HIV-1 subtypes B and AE
por: van der Sluis, Renée M, et al.
Publicado: (2011)

Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers
por: de Azevedo, Suwellen S. D., et al.
Publicado: (2017)

Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA
por: Tumiotto, Camille, et al.
Publicado: (2017)

HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy
por: Omondi, F. Harrison, et al.
Publicado: (2021)

Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting
por: Lilie, Tyler, et al.
Publicado: (2023)

Novel assays to investigate the mechanisms of latent infection with HIV-2
por: Lu, Michael D., et al.
Publicado: (2022)

Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA
por: Booth, Clare L, et al.
Publicado: (2014)

HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA
por: Nascimento-Brito, Sieberth, et al.
Publicado: (2015)

HIV-1C proviral DNA for detection of drug resistance mutations
por: Huruy, Kahsay, et al.
Publicado: (2018)

Identification and characterization of a novel enhancer in the HTLV-1 proviral genome
por: Matsuo, Misaki, et al.
Publicado: (2022)

HIV-PULSE: a long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization
por: Lambrechts, Laurens, et al.
Publicado: (2023)

Excision of HIV-1 Proviral DNA by Recombinant Cell Permeable Tre-Recombinase
por: Mariyanna, Lakshmikanth, et al.
Publicado: (2012)

The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
por: Zhu, Weijun, et al.
Publicado: (2015)

Longitudinal comparison of HIV-1 plasma viral load and cellular proviral load
por: Schweitzer, Finja, et al.
Publicado: (2014)

Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA
por: Meinke, Gretchen, et al.
Publicado: (2017)

Correction: HIV-1C proviral DNA for detection of drug resistance mutations
por: Huruy, Kahsay, et al.
Publicado: (2018)

Use of Proviral DNA to Investigate Virus Resistance Mutations in HIV-infected Zimbabweans
por: Musingwini, Tutsirai V., et al.
Publicado: (2017)

108. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy
por: Gandhi, Rajesh, et al.
Publicado: (2020)

HIV proviral DNA integration can drive T cell growth ex vivo
por: Yoon, John K., et al.
Publicado: (2020)

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)
por: Kinloch, Natalie N., et al.
Publicado: (2021)

CpG Methylation Profiles of HIV-1 Proviral DNA in Individuals on ART
por: Boltz, Valerie F., et al.
Publicado: (2021)

Ongoing HIV-1 evolution and reservoir reseeding in two elite controllers with genetically diverse peripheral proviral quasispecies
por: de Azevedo, Suwellen Sardinha Dias, et al.
Publicado: (2023)

Proviral Quasispecies Diversity Is Not Associated With Virologic Breakthrough or CD4(+) T Cell Loss in HIV-1 Elite Controllers
por: de Azevedo, Suwellen S. D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i3n9pvg11cr43f89edrqb89kcj